Fixed Dose Combination of Voglibose & Repaglinide in the Management of Postprandial Hyperglycemia in Indian Subjects

Journal Title: Global Journal of Obesity, Diabetes and Metabolic Syndrome - Year 2017, Vol 4, Issue 3

Abstract

To evaluate the efficacy and tolerability of fixed dose combination of voglibose and repaglinide in postprandial hyperglycemia (PPHG) in Indian subjects. A non-randomized, open labeled, non-comparative, single-centric, study was conducted in total of 20 type 2 diabetes mellitus (T2DM) patients (9 men and 11 women, mean age 69.07 ± 3.495 years). Each patient was administered a fixed dose combination of voglibose 0.3mg and repaglinide 0.5/1mg three times a day, just before each meal for 30 days. Fasting blood glucose (FBG) and postprandial blood glucose (PPBG) was performed at baseline and at the end of study as assessment tools. At the end of study data was extractable only in 15 patients because 5 patient dropped out as they did not turn up for follow up at day 30.Postprandial blood glucose reduced significantly {-61.67mg/dl (95% confidence interval -76.79 to -46.54 p<0.0001)} from baseline at day 30. Also a significant reduction (p<0.0001) was found with FBG {-42.13mg/dl (Confidence interval -61.25 to -23.02 P value <0.0001)} at end of day 30. There were no adverse events reported including hypoglycemia. Voglibose and Repaglinide combination was effective and safe for the management of PPHG in T2DM patients.

Authors and Affiliations

Faruqui Arif

Keywords

Related Articles

Diabetes mellitus and heart diseases

Diabetes mellitus is recognized by World Health Organisation experts as a non-communicable epidemic and represents a serious medical and social problem. In 2012, suffered of diabetes mellitus about 6.4% (285 million) of...

Delivery of Nanoparticles for the Treatment of Cardiovascular Diseases

Cardiovascular diseases are still one of the major causes of death for the people in the world. Biomedical implantable devices are the basic approach on the treatment of cardiovascular diseases. However, unexpected and s...

The Investigation of the Awareness of Osteoporosis in Postmenopausal Women

Background and Aims: The awareness of osteoporosis is essential of treatment. We investigated the awareness of osteoporosis in the patients with postmenopausal women in the region of Northeastern Anatolia, Turkey. Method...

Sinapic Acid Regulates Glucose Homeostasis by Modulating the Activities of Carbohydrate Metabolizing Enzymes in High Fat Diet Fed-Low Dose STZ Induced Experimental Type 2 Diabetes in Rats

Diabetes Mellitus is a chronic metabolic disorder arises due to absolute lack of insulin secretion (T1DM) or its action or both (T2DM). Alterations in glucose metabolism in DM are frequently accompanied by impairment in...

Complications from Laparoscopic Adjustable Gastric Banding: 364 Cases Experience

Background: Laparoscopic adjustable gastric banding LAGB procedures are part of bariatric surgery, it has been reported with favorable risk-benefit profile like part of the management of obesity. These procedures are eff...

Download PDF file
  • EP ID EP343908
  • DOI 10.17352/2455-8583.000026
  • Views 88
  • Downloads 0

How To Cite

Faruqui Arif (2017). Fixed Dose Combination of Voglibose & Repaglinide in the Management of Postprandial Hyperglycemia in Indian Subjects. Global Journal of Obesity, Diabetes and Metabolic Syndrome, 4(3), 63-65. https://europub.co.uk/articles/-A-343908